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Abstract
Background: Tsetse flies (Glossina sp.), the African trypanosome vectors, rely on anti-hemostatic compounds for efficient
blood feeding. Despite their medical importance, very few salivary proteins have been characterized and functionally
annotated.
Methodology/Principal Findings: Here we report on the functional characterisation of a 59nucleotidase-related (59Nuc)
saliva protein of the tsetse fly Glossina morsitans morsitans. This protein is encoded by a 1668 bp cDNA corresponding at
the genomic level with a single-copy 4 kb gene that is exclusively transcribed in the tsetse salivary gland tissue. The
encoded 59Nuc protein is a soluble 65 kDa glycosylated compound of tsetse saliva with a dual anti-hemostatic action that
relies on its combined apyrase activity and fibrinogen receptor (GPIIb/IIIa) antagonistic properties. Experimental evidence is
based on the biochemical and functional characterization of recombinant protein and on the successful silencing of the
59nuc translation in the salivary gland by RNA interference (RNAi). Refolding of a 59Nuc/SUMO-fusion protein yielded an
active apyrase enzyme with Km and Vmax values of 4364 mM and 684649 nmol Pi/min6mg for ATPase and 49611 mM and
177637 nmol Pi/min6mg for the ADPase activity. In addition, recombinant 59Nuc was found to bind to GPIIb/IIIa with an
apparent KD of 92625 nM. Consistent with these features, 59Nuc potently inhibited ADP-induced thrombocyte aggregation
and even caused disaggregation of ADP-triggered human platelets. The importance of 59Nuc for the tsetse fly hematophagy
was further illustrated by specific RNAi that reduced the anti-thrombotic activities in saliva by approximately 50% resulting
in a disturbed blood feeding process.
Conclusions/Significance: These data show that this 59nucleotidase-related apyrase exhibits GPIIb/IIIa antagonistic
properties and represents a key thromboregulatory compound of tsetse fly saliva.
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Introduction
Efficient acquisition of a blood meal by hematophagous
arthropods relies on a broad repertoire of physiologically active
saliva components inoculated at the blood feeding site. These are
primarily anti-hemostatic components that interfere with host
responses such as vasoconstriction [1,2], primary hemostasis
through the adherence and aggregation of thrombocytes [3,4]
and a secondary hemostatic cascade mainly relying on serine
proteases such as thrombin [5,6]. In the formation of the primary
hemostatic plug, adenosine-59-triphosphate (ATP) and adenosine-
59-diphosphate (ADP) released from injured cells and activated
platelets, interact with purinergic P2 receptors (P2X1 for ATP and
P2Y1 and P2Y12 for ADP) and fulfil key roles in the activation and
aggregation of platelets and strongly contribute to the amplifica-
tion of the initial hemostatic response [reviewed in [7,8]]. ADP
acts on the G protein-coupled P2Y1 and P2Y12 receptors resulting
in thrombocyte shape change, aggregation (through activation of
the fibrinogen receptor) and the production of thromboxane A2
that has prothrombotic properties. ATP binds onto the cation-
gated P2X1 receptor that is present on thrombocytes resulting in
cytoskeletal reorganisation and higher responsiveness in terms of
aggregation and degranulation towards other platelet activating
triggers such as collagen [reviewed in [7,8]]. To overcome these
ATP- and ADP-related host responses, blood sucking insects have
ATP/ADP-hydrolysing [ATP(D)ase] enzymes present in their
salivary secretions [9]. These enzymes are often called apyrases
(nucleosidetriphosphate diphosphohydrolases) and have been
described in the saliva of a variety of blood feeding arthropods
such as Cimex lectularius bed bugs [10], Ixodes dammini ticks [11],
Aedes aegypti and Anopheles gambiae mosquitoes [12,13], Phlebotomus
papatasi sand flies [14] and Triatoma infestans reduviids [15]. These
apyrases were shown to mainly belong to two different genetic
families: one group of apyrases belongs to the 59-nucleotidase gene
family that has been described in several hematopaghous
arthropod species [13,15], while a completely different type of
apyrases has been found in bed bugs (Cimex sp.) and sand flies
[10,14,16]. However, all these apyrases are cation-dependent
enzymes that release inorganic phosphate (Pi) from ATP and ADP
but not from AMP, thereby inhibiting the purinergic activation
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thromboregulatory role, apyrases present in the saliva of blood
feeding arthropods have also been implicated in anti-inflammation
by the degradation of ATP as agonist of the inflammatory
purinergic receptors [17]. As such, salivary apyrases of hema-
tophagous arthropods could inhibit several aspects of hemostasis
and inflammation thereby promoting the blood feeding process
and possibly facilitating pathogen transmission, a feature that we
have described for the saliva of tsetse flies, blood feeding insects
that transmits the protozoan agents of African trypanosomiasis
[18].
In the tsetse fly, the presence of salivary ATP(D)ases has been
suggested by the observation that ADP-induced thrombocyte
aggregation is inhibited by an unidentified apyrase activity of
.30kDa [4]. Strikingly, tsetse saliva could also disaggregate ADP-
triggered platelets which was attributed by the authors to the
apyrase enzymatic activity. In this study, we report on the
identification of a 59nucleotidase-related protein in Glossina
morsitans morsitans and provide molecular, biochemical and
functional evidence that this is the major apyrase in tsetse saliva
that is also able to bind to the fibrinogen receptor and inhibit and
reverse ADP-induced platelet responses.
Results
In silico analysis of the 59Nuc cDNA
Screening of the lgt11 salivary gland cDNA library with the
385 bp 59Nuc probe and subsequent sequencing of 5 positive
clones identified a full-length 59nucleotidase encoding cDNA
of 1976 bp. (Fig. 1A). In silico analysis revealed a 102-bp 59-
untranslated region followed by an open reading frame corre-
sponding to 555 amino acid residues and a 185-bp 39-untranslated
region that contains a polyadenylation signal (EMBL: AF384674).
Sequence analysis of the predicted translation product, de-
signated as G. m. morsitans 59nucleotidase-related protein (59Nuc),
identified the first 25 amino acids as a potential signal peptide
leaving a mature protein of 530 amino acids with a calculated
molecular weight of 59375 Da and an isoelectric point of 7.32.
Figure 1. In silico analysis of the 59Nuc cDNA. (A) Alignment of the G. m. morsitans 59nucleotidase conceptual translation product with several
members of the 59nucleotidase family. Homologous residues are shown on a shaded background, residues that were identified for E. coli 59Nuc to be
important for catalysis, substrate and cofactor binding are indicated on an orange background. (B) Amino acids predicted to be involved in catalytic
activity and co-factor and substrate binding of the E. coli 59nucleotidase and their homologous residues in tsetse 59Nuc (C). Structure prediction of
tsetse 59Nuc relying on comparison of Hidden Markov Models, based on resolved structures of homologous 59nucleotidases. The predicted structure
of tsetse 59Nuc and the resolved structures of Escherichia coli and Thermus thermophilus 59nucleotidases are depicted (respective PDBs: 1h05 and
2Z1a).
doi:10.1371/journal.pone.0009671.g001
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80, Asn
173, Asn
270 and
Asn
440) and 2 O-glycosylation sites (Thr
256 and Thr
389) were
identified. BLAST analysis revealed significant sequence similar-
ities to a group of enzymes belonging to the 59-nucleotidase family
(Table S1) but lacks a hydrophobic C-terminal domain that sig-
nals for glycosylphosphatidylinositol anchoring. High degrees of
similarity were apparent within the seven domains known to
characterize enzymes exhibiting 59nucleotidase activity [13]
(Fig. 1A). Residues that were documented for E. coli 59nucleotidase
to be crucial for co-factor and substrate binding and catalytic
activity [19,20] are all present in the G. m. morsitans 59nucleotidase-
related protein (Fig. 1B). Structure modelling based on comparison
of hidden Markov models, suggested strong structural similarity
with resolved structures of the Escherichia coli and Thermus
thermophilus 59nucleotidase (respective PDBs: 1hO5 and 2Z1a,
Fig. 1C).
Identification of the 59Nuc gene and expression analysis
The 59Nuc structural gene of .4 kb including the 59 and the 39
UTRs was identified and revealed by Southern blot analysis to be
present as a single copy in the tsetse fly genome. The gene was
shown to contain 7 introns, including two with the size of
approximately 1 kb (Fig. 2A). Northern blot analysis using salivary
gland RNA corroborated that the gene resulted in a single
transcript of around 1.7 kb, corresponding to the identified
1668 bp coding sequence (data not shown).
RT-PCR analysis revealed that 59Nuc transcription occurs
exclusively in the salivary glands (Fig 2B). Western blot analysis
with anti-59Nuc polyclonal rabbit serum resulted in a strong
positive reaction around 65 kDa and a significantly weaker signal
for the 125–140 kDa protein bands (previously identified as sgp3
that consists of a 59nucleotidase domain, EMBL:EF398273, [21])
in the tsetse fly saliva (Fig. 2C). The molecular weight of 65 kDa as
compared to the predicted 59.4 kDa suggested the presence of
glycosyl modifications, as demonstrated using a glycosylation
detection reagent and a mobility shift of about 5 kDa after
PNGase F treatment (data not shown). In the soluble extract of the
foregut/proventriculus tissue, a weak but significantly positive
signal around 65 kDa could be detected (Fig. 2C), suggesting
overflow of salivary proteins into this part of the alimentary tract.
In teneral (newly emerged, non-fed) flies and at different time
points after blood feeding, the relative abundance of the 65 kDa
59Nuc protein in the total saliva protein pool remained at a similar
constant level (data not shown).
Total tsetse fly saliva exerts ATP(D)ase activity
Tsetse fly saliva exerts ATP(D)ase activity as illustrated in kinetic
assays using ATP and ADP as substrates followed by determining
the inorganic phosphate (Pi) release. No AMPase activity could be
detected, illustrating that tsetse salivary nucleotidases exert apyrase
activity. Beside ATP and ADP, other nucleoside triphoshate and
diphosphates substrates were converted such as rATP.rGT-
P=rUTP and rADP=rUDP.rCDP (data not shown). Separa-
tion of total tsetse saliva under native conditions followed by
zymographic ATPase detection revealed activity confined to the
upper four high molecular weight protein complexes (Fig. 3A) that
Figure 2. Identification of the 59Nuc gene and its expression profile in tsetse flies. (A) Representation of the G. m. morsitans 59Nuc gene as
compared to the Aedes aegypti apyrase gene [12] with indication of intron and exon sizes, promoter and terminator regions. (B) RT-PCR based
detection of 59nucleotidase transcription in proventriculus, midgut and salivary gland tissue of 15-days-old male tsetse flies. The a-tubulin gene
transcription was used as positive control. (C) Western blot analysis using rabbit anti-59Nuc IgGs to evaluate the presence of the 59Nuc protein in the
proventriculus, midgut and salivary gland tissue of differently aged male tsetse flies.
doi:10.1371/journal.pone.0009671.g002
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Analysis of the pH dependence revealed alkaline pH optima
around 8.0 and 9.5 (Fig. 3B). This salivary apyrase activity is
dependent on divalent ions as cofactors with a preference for Mg
2+
and Mn
2+ and is completely inhibited by the addition of EDTA
(data not shown).
In vivo functional analysis of 59Nuc by RNA interference
(RNAi)
RNAi was applied for in vivo functional analysis of 59Nuc by
intrathoracal injection of 15 mg dsRNA per fly. This resulted in a
highly specific knockdown of the 65 kDa 59nucleotidase with 90%
reduction at the mRNA level without silencing the homologous
sgp3 gene (Fig. S1). A maximal translational silencing of 75% was
obtained at day 12 post injection as illustrated by densitometric
analysis after SDS-PAGE (Fig. 4A). Saliva from these RNAi-
treated and control dsRNA injected tsetse flies was compared in a
Pi-release based ATP(D)ase assay revealing an inhibition of the
salivary ATPase activity by 49% and ADPase activity by 45%
(Fig. 4B). As a result of silencing, feeding efficiencies on
anesthetized mice of 59Nuc RNAi flies (64612 mg/s, n=32) were
significantly lower (p=0.037, Fig. 4C) than those of control RNAi
treated individuals (88612 mg/s, n=41). Indeed, flies with
reduced salivary apyrase activity generally acquired smaller blood
meals (13.061.5 mg versus 16.861.7 mg, p=0.061) and required
slightly longer times to complete blood feeding (267628 s versus
248627 s, p=0.200). Evaluation of the inhibition of ADP-induced
thrombocyte aggregation by K serially diluted saliva samples from
RNAi treated flies (5 – 0.625 mg/ml, Fig. 4D), revealed an
approximate 50% activity reduction upon 59Nuc silencing. Also
the capacity of saliva to disaggregate ADP-triggered platelets was
reduced to a similar degree by 59Nuc knockdown. To illustrate
that the knockdown specifically affects the 59Nuc activity, the
potent inhibitory activity of tsetse saliva to bovine thrombin
remained unaffected after 59Nuc RNAi (data not shown).
Refolding of recombinant 59Nuc/SUMO fusion protein
Recombinant 59Nuc/SUMO fusion protein, purified from
inclusion bodies using immobilized metal affinity chromatography,
was refolded by rapid dilution in different non-denaturing buffers.
Various pH conditions (pH 4.0 to 10) in combination with
additives such as 0.5 M L-arginine, 10 mM b-mercaptoethanol
and oxidized/reduced glutathion (0.1 mM/1 mM) were tested.
Primary read-out for the resolubilisation and refolding efficiency
were precipitation (O.D. 405nm) and ATPase activity (Fig. 5A).
Recombinant 59Nuc could be readily solubilized in alkaline buffers
from pH 8 onwards without the addition of L-arginine. Gain-of-
activity was obtained without the requirement of an oxido-
shuffling system (Fig. 5A). Moreover, reducing agents such as b-
mercaptoethanol and dithiothreitol did not affect ATPase activity,
illustrating that disulfide bridges are not required for activity of
59Nuc.
Enzymatic characteristics of refolded 59Nuc/SUMO fusion
protein
Refolded monomeric 59Nuc exerted ATPase and ADPase but
no AMPase activity, similar to what was observed for total tsetse
fly saliva. Evaluation of the pH dependence illustrated a
preference for alkaline conditions, with an optimum at pH 8.0
for both ATPase and ADPase activity (Fig. 5B). Different
nucleoside triphosphate and diphoshate substrates could be
converted such as rATP&dATP=dTTP.rGTP=rUTP and
rADP=rUDP.rCDP (Fig. 5C). The temperature optimum for
the ATP(D)ase activity was around 40uC but remained high in a
broad range of suboptimal temperature conditions (20u–47uC)
(Fig. 5D). Similar as for total saliva, ATPase and ADPase activities
of the recombinant 59Nuc depended on divalent ions with a
preference for Mn
2+ and Mg
2+. To a lesser extent, Ca
2+ could also
activate ATPase and ADPase activity, while Cu
2+,N i
2+ and Co
2+
support mainly ADPase activity (Fig. 5E). ATPase and ADPase
experiments that were performed with total tsetse fly saliva
(Fig. 6A) and refolded 59Nuc (Fig. 6B) suggested that the native
and recombinant enzymes obeyed Michaelis-Menten kinetics,
allowing the estimation of Km and Vmax from non-linear
regression analyses. Km values were determined in three
independent experiments, being 4364 mM for ATPase and
49611 mM for ADPase activity of recombinant 59Nuc. Vmax
values were determined to be 684649 and 177637 nmol Pi/
min6mg for respectively ATPase and ADPase activities (Fig. 6C).
Comparable Km (3364 mM for ATPase and 1963 mM for
ADPase) and Vmax values (791627 and 239611 nmol Pi/
min6mg respectively) were obtained for total tsetse fly saliva.
Kcat/Km ratios confirmed a substrate preference of 59Nuc for ATP
over ADP (Fig. 6C).
Figure 3. Apyrase activity in tsetse fly saliva. (A) Coomassie stained tsetse fly salivary proteins separated under native conditions. Protein bands
1 to 4 exerted ATPase activity as revealed by zymography. (B) pH dependence of the salivary ATP(D)ase activity, revealing two apparent alkaline pH
optima (pH 7.8–8.6 and pH 9.4–9.6). No AMPase activity could be detected. Shown data are the compiled and representative results from five
experiments using different saliva concentrations (1, 2.5 and 5 mg/ml).
doi:10.1371/journal.pone.0009671.g003
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their influence on the ATP(D)ase activity of 59Nuc. While 1 mM
of the Na
+/K
+-ATPase inhibitor ouabain and alkaline phospha-
tase inhibitor levamisole had no influence on 59Nuc, 1 mM
adenosine, AMP and AP5A as well as 1 mM vanadate and
10 mM NaN3 had moderate inhibitory effects on enzymatic
activity (Table S2). DEPC (2 mM), sodium fluoride (10 mM) and
4,49 diisothiocyanostylbene 2,29 disulfonic acid (DIDS, 100 mM)
nearly completely abrogated substrate conversion while conca-
navalin A enhanced the activity as has been described for other 59
nucleotidases (Table S2).
Fibrinogen receptor (GPIIb/IIIa) binding properties of
refolded 59Nuc/SUMO fusion protein
To evaluate the fibrinogen receptor antagonistic properties of
59Nuc/SUMO, its binding to solid-phase immobilized GIIb/IIIa
was evaluated. Using both a SUMO-Tag specific and an anti-
59Nuc IgG based detection, concentration-dependent 59Nuc
binding onto the purified receptor could be demonstrated. Based
on four experiments, an apparent KD of 92625 nM was
calculated. To further illustrate the specificity of the binding,
inhibition studies were performed using varying concentrations of
purified human fibrinogen (Fig. 7). These illustrated a dose-
dependent inhibition of 59Nuc binding by fibrinogen, further
confirming that the tsetse fly 59Nuc has GIIb/IIIa receptor-
specific antagonistic properties.
Platelet inhibitory properties of refolded 59Nuc/SUMO
fusion protein
Recombinant 59Nuc/SUMO protein was assessed for its
activity on human platelets using an aggregation assay in
microtiter plates. Similar as for total tsetse fly saliva, the
recombinant protein inhibited ADP-induced platelet aggregation
and even caused disaggregation of thrombocytes in a dose-
dependent manner (Fig. 8A). Pre-incubation of ADP with the
recombinant protein completely abrogated the ADP-induced
platelet response (Fig. 8A). Exposure of maximally ADP-
aggregated platelets to saliva or recombinant 59Nuc resulted in a
disaggregation response that for 59Nuc was significant at the
highest tested concentration of 20 mg/ml (Fig. 8B).
Discussion
Tsetse fly saliva is a complex mixture of proteins that is essential
for the blood feeding process which requires the creation of a
blood pool at the bite site and the maintenance of blood fluidity in
the mouthparts, crop and anterior midgut. Previously, it was
shown that an ADP-hydrolyzing activity, present in a crude
salivary extract, can inhibit platelet aggregation (Mant & Parker,
1981).
In this report, we functionally characterized a secreted 65 kDa
59nucleotidase-related protein (59Nuc, EMBL: AF384674) as a
major apyrase and fibrinogen receptor (GPIIb/IIIa) antagonist
Figure 4. 59Nuc specific silencing by RNA interference. (A) Coomassie stained protein profiles of saliva harvested from control RNAi
(lane 1) and 59Nuc RNAi treated flies (lane 2) at day 12 post injection. The 59Nuc protein band (confirmed by western blot analysis) is
indicated with an arrow. (B) Inhibition (%) of respectively ATPase and ADPase activities by selective knockdown of 59Nuc expression. (C)
Blood feeding experiment monitoring the effect of silencing on feeding efficiency at day 12 after dsRNA injection. Influence of serially
diluted saliva (2.5 – 0.625 mg/ml) from control (solid lines) and 59Nuc RNAi treated flies (dotted lines) on (D) ADP-induced platelet
aggregation and (E) disaggregation of maximally ADP-aggregated platelets. These results are representative of at least two independent
experiments.
doi:10.1371/journal.pone.0009671.g004
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protein pool [21]. Experimental evidence is based on the successful
suppression of 59Nuc transcription in the tsetse salivary gland by
RNA interference and on the production of functional recombi-
nant protein with characteristics that are nearly identical to the
native activity. This recombinant 59Nuc still had a strong tendency
to aggregate in inclusion bodies despite the presence of a SUMO-
chaperone for better folding [22]. However, the advantage of
purifying 59Nuc from these inclusion bodies was the possibility to
obtain homogeneous preparations, as problems of proteolytic
degradation and copurification with contaminants has precluded
biochemical characterisation of several orthologs. Out of the
different refolding conditions that were tested, it was sufficient to
make a fast dilution of the protein into a non-denaturing alkaline
buffer with pH.8.0, without the need of folding-assisting agents to
obtain a good yield of active protein. Successful refolding in similar
alkaline conditions has also been reported for rat NTPase
ectodomains [23]. The active monomeric 59Nuc that we obtained
by size exclusion chromatography after refolding was clearly
an apyrase as it excluded AMP as substrate. Preferred substrates
were rATP, rADP and rUDP while other nucleoside tri- and
diphosphates were less potently converted. The enzyme had also a
preference for ribonucleoside over deoxyribonucleoside triphos-
phates as rATP was a much better substrate than dATP. These
base and sugar preferences of 59Nuc provide the enzyme with the
most relevant nucleotide specificities (for rATP and rADP as
platelet triggers) in the context of anti-hemostasis. Co-factor
studies using recombinant protein and total tsetse fly saliva
identified Mn
2+ and Mg
2+ as most effective, while Ca
2+ could only
induce moderate activity. This is similar to the triatomine
59nucleotidase related apyrase [15], while most other identified
apyrases of blood feeding insects have a cofactor preference for
Ca
2+ [10,14,24]. Cu
2+ and Ni
2+ were also found to activate the
enzyme (primarily stimulating ADPase activity), similar as for
some E. coli nucleotidases [25], whereas Cd
2+ and Zn
2+ could not
induce the tsetse fly 59Nuc although these are suitable cofactors for
the E. coli homologue [19]. Assumptions on the mechanism of
substrate dephosphorylation as well as a prediction of the tsetse
59Nuc structure could be made based on previous studies on the
homologous E. coli 59nucleotidase [19,20]. Structure prediction
suggested a protein fold consisting of two domains, linked through
an a-helix (see Fig. 1C). The E. coli homologue has the ability to
shift between an open (inactive) and closed (active) conformation
as a result from an interdomain rotation of 96u. At the interphase
of the two domains, at the C-terminal end of 2 sandwiched
babab-motifs, the dimetal catalytic site is located. All residues that
Figure 5. Enzymatic characterization of the 59Nuc/SUMO fusion protein. (A) Refolding efficiency of 59Nuc in different pH conditions (pH 4.0
to 10.0: 25 mM buffers of sodium acetate, MES, HEPES, Tris and piperazin supplemented with 250 mM NaCl, 5 mM KCl, 1 mM CaCl2 and 1 mM MgCl2)
in the presence of additives such as 0.5 M L-arginine, 10 mM b-mercaptoethanol and an oxido-shuffling system (1 mM reduced and 0.1 mM oxidized
glutathion). Primary read-outs for efficiency were precipitation (O.D. at 405 nm., empty bars, left Y-axis) and ATPase activity (% relative activity, filled
bars, right Y-axis) determined using a malachite green based Pi-release assay (B) pH dependence of the ATP(D)ase activity over a pH range from 3.0 to
12.0. Represented activities (nmol Pi/min6mg) were calculated from the specific Pi-release by 2.5 mg/ml recombinant protein from 20 mM ATP and
ADP substrates in the respective buffers supplemented with 100 mM NaCl and 1 mM CaCl2 and 1 mM MgCl2 (C) Ribonucleoside and
deoxyribonucleoside triphosphates and ribonucleoside diphosphate specificities were determined in a kinetic assay using 20 mM of the individual
substrates in the presence of 1mM Mg
2+ and 1mM Ca
2+ at pH 8.0. Activities were calculated percentual to the rATPase activity. (D) Temperature
dependence of recombinant 59Nuc in an interval between 20 and 60uC. Activities (%) were calculated as relative to those measured in optimal
temperature conditions. (E) Percentage ATPase and ADPase activity in the presence of different co-factors (Ca
2+ Mg
2+,C o
2+,M n
2+,C d
2+,C u
2+,Z n
2+
and Ni
2+) was measured in the presence of 0.1 mM EDTA and EGTA. The enzyme was pre-incubated for 15 minutes with the different co-factors prior
to addition of 20 mM substrate. Activity was measured over 60 minutes and calculated within the linear phase of substrate conversion. All data are
representative of at least two independent experiments.
doi:10.1371/journal.pone.0009671.g005
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also present in the homologous Glossina m. morsitans 59Nuc (Asp
38,
His
40, Asp
91, Asn
123, His
124, His
249). Only the E. coli Gln
254 is
substituted by a histidine (His
251), a replacement which is also
found in e.g. human, Drosophila and Anopheles gambiae5 9Nuc. The
Asp-His dyad that is part of the catalytic core structure as well as
most of the residues that constitute the substrate binding pocket
are conserved in tsetse 59Nuc (respectively His
124 and Asp
127 and
Arg
354, Arg
358, Arg
402, Phe
421 and Phe
505). The crucial involve-
ment of the bivalent cations and the histidine that might function
as a general base to drive the nucleophilic attack by one of the
coordinated water molecules was illustrated by the efficient
inhibition by respectively EDTA and DEPC. Disulfide bridges
and glycosylation were suggested to have little influence on the
core structure and enzymatic function of other 59nucleotidase
because the involved cystein residues are already in close
proximity and glycosylated asparagine residues are located at the
surface of the molecule [26]. Our data indeed show that reducing
agents (b-mercaptoethanol and DTT) do not affect catalytic rates
and that the non-glycosylated recombinant protein (expressed in
E. coli) exerts potent activity. The fact that AMP does not serve as a
substrate might suggest that AMP is not properly accommodated
in the active site and that the a-phosphate group cannot be
hydrolytically removed by the tsetse 59Nuc. Given that AMP as
well as adenosine and AP5A had some inhibitory effects (20–50%)
on 59nucleotidase activity at a 506molar excess, these adenosine
derivatives probably bind to the active site with low affinity, where
the Phe
429 and Phe
498 residues could be responsible for stacking of
the adenine ring [20]. Nevertheless, the functional result is that the
saliva converts ATP and ADP released at the bite site not further
than AMP, where AMP has been suggested to promote the blood
feeding process by inducing vasodilatation [27]. As adenosine is
not produced, the functional relevance of two tsetse fly salivary
proteins with putative adenosine deaminase activity, tsetse salivary
gland growth factors 1 and 2 (TSGF-1 and TSGF-2) [28], remains
unclear.
Biochemical characterisation of the refolded recombinant
59Nuc/SUMO protein revealed Km values that were in the low
micromolar range (43 mM and 49 mM) and maximal enzymatic
rates of 684649 and 177637 nmol Pi/min6mg or 0.68 and
0.18 U/mg for respectively ATPase and ADPase. Although
limited biochemical information is available on apyrases of blood
feeding arthropods, the measured Km values were comparable to
those described for e.g. a recombinant mosquito (Aedes aegypti)
apyrase [29] and the porcine hepatic canalicular ATP(D)ase [30].
With the definition of 1 unit corresponding to the amount of
enzyme required to release 1 mmol of Pi/min and the fact that
tsetse flies inoculate approximately 4 mg saliva at the feeding site to
obtain a 20 ml blood meal, this would correspond to 100 mU/ml
Figure 6. Determination of 59Nuc biochemical parameters. Michaelis Menten plot illustrating the Pi release by (A)1mg/ml total tsetse fly
saliva and (B) 2.5 mg/ml 59Nuc from increasing concentrations of ATP and ADP substrate (0.78 to 500 mM) in a 200 ml reaction volume in the presence
of 1 mM Mg
2+ and Ca
2+.( C) Kinetics values (Km, Vmax, Kcat and Kcat/Km) for recombinant 59Nuc/SUMO fusion protein, determined based on three
experiments.
doi:10.1371/journal.pone.0009671.g006
Figure 7. 59Nuc binding onto purified human fibrinogen
receptor (GPIIb/IIIa). 59Nuc binding (250, 125 and 62.5 nM) onto
solid-phase immobilized GIIb/IIIa in the presence of varying concentra-
tions of fibrinogen (20 – 0.05 nM), detected using a rabbit anti-59Nuc
polyclonal IgG. These results are representative of two independent
experiments.
doi:10.1371/journal.pone.0009671.g007
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0.24 U/mg for saliva). This inoculated activity, which is confined
to 4 high molecular weight (HMW) protein complexes as revealed
by native gel separation and zymography, would theoretically be
sufficient to convert local concentrations of 200 mM ATP and
70 mM ADP within an average feeding time of 4 minutes. The
physiological advantage of these HMW complexes could be the
centralization and potentation of several pharmacological activities
similar as what has been described for snake venom (reviewed in
[31]) and a reduction in diffusion rate from the blood pool where
the tsetse fly feeds.
The exclusive expression of 59Nuc in the salivary gland tissue
suggested that the activity is primarily required in the saliva
inoculum at the bite site. In this context, the potency of tsetse
saliva to counter ADP-induced hemostasis has been previously
documented [4] and our thrombocyte aggregation assays have
illustrated the potency of 59Nuc to inhibit and even reverse ADP-
induced platelet responses, a feature which was also described for a
59nucleotidase related fibrinogen receptor (GPIIb/IIIa) antagonist
in the saliva of Chrysops deerflies [32]. 59Nuc/SUMO binding
studies onto purified human GPIIb/IIIa combined with fibrinogen
inhibition studies have clearly illustrated that the tsetse fly 59Nuc is
also a fibrinogen receptor antagonist, where the recombinant
protein displayed an apparent KD of 92625 nM. This feature is
likely causally linked to the platelet disaggregating potential of
59Nuc in tsetse fly saliva. The binding mode of 59Nuc and the
homologous chrysoptin to GPIIb/IIIa remains to be elucidated, as
both lack the characteristic RGD-motif that has been recurrently
found in other fibrinogen receptor antagonists [32]. Moreover,
these data illustrate that, unlike chrysoptin, the glycosylation is not
absolutely required for GPIIb/IIIa binding of the tsetse fly 59Nuc.
In addition to influencing ADP-induced hemostasis, mediated
through P2Y1 and P2Y12 receptor ligation and involving
downstream fibrinogen-mediated reactions, substrate preference
of 59Nuc for ATP suggested that interference with ATP-based host
reactions plays an important role in the blood feeding process. It is
known that ATP can bind to the P2X1 receptor on platelets
thereby amplifying their responsiveness to various activating
stimuli. This feature has been illustrated to especially contribute
to hemostasis in high shear rate conditions that might occur in the
microvasculature at the blood feeding site [33]. Beside the
involvement in thromboregulation, extracellular ATP was also
shown to induce IL-1b and IL-18 and to stimulate phagosome-
lysosome fusion in macrophages [34,35], to provoke chemotaxis
and distorted maturation of dendritic cells [36,37] and to amplify
the chemotactic gradient that orients granulocyte migration [38].
In line with these properties of ATP and ADP, the presence of
ectonucleotidase activities on the surface of various cell types has
been shown to be important in thromboregulation [39] and the
control of inflammatory reactions in the host [40,41]. As such,
salivary apyrases of hematophagous arthropods might not only
inhibit several aspects of hemostasis but also reduce inflammation
at the bite site. Possibly, the documented anti-inflammatory
properties of nucleotidases explain the salivary immunomodula-
tory action that we have previously described to promote
trypanosome infection onset [18].
In addition to its activity at the blood feeding site, analysis of the
apyrase activity in total saliva revealed that optimal activities were
obtained in alkaline pH conditions that corresponded to the
measured pHs in respectively saliva (pH 7.8) [21] and the
proventricular tract (pH 9.5). Together with the observation that
59Nuc leaks into the proventriculus, this suggested that the activity
is not restricted to the salivary gland and micro-environment of the
bite site but that it might also act in the upper part of the
alimentary tract. Our in vivo gene silencing experiments revealed
that 59Nuc supports the blood feeding process as evidenced by
slower feeding rates for RNAi-treated flies that generally obtained
smaller blood meals and required slightly longer times to feed.
This blood feeding phenotype resulted from a 50% knockdown of
apyrase and anti-thrombotic activity despite the remaining 25%
59Nuc protein and the presence of another putative apyrase in
tsetse fly saliva, the sgp3 protein that we have previously identified
[21] and that remained unaffected by the RNAi. Detailed analysis
of the salivary gland EST database ([42], http://www.genedb.
org/genedb/glossina/) further supports the strong dominance of
the 59nuc that is represented by 25 ESTs in a total of 37 EST
clusters putatively encoding 59nucleotidase-related proteins. An-
other cluster of 10 ESTs encodes Sgp3 that still remains to be
characterized as a true apyrase, while another candidate, GM-544,
is only represented by 2 ESTs that are moreover truncated at the
39 end. Collectively, based on the in vivo silencing, the biochemical
analyses and platelet aggregation assays, we have calculated that
the 65 kDa 59Nuc accounts for approximately 65% of the total
ATP/ADP-hydrolyzing activity and the bulk of the anti-platelet
aggregation/disaggregating activity in tsetse saliva and have
uncovered its fibrinogen receptor antagonistic potential. These
data clearly illustrate the important anti-hemostatic role of 59Nuc
Figure 8. 59Nuc thromboregulatory activity. (A) Inhibitory action
of 59Nuc (10 and 20 mg/ml, simultaneous or preincubated with the
10 mM ADP) and saliva (10 mg/ml) on ADP-induced platelet aggrega-
tion. (B) Disaggregating potential of saliva and 59Nuc on ADP-
aggregated thrombocytes. Addition of ADP and disaggregants are
indicated with arrows. These results are representative of at least two
independent experiments.
doi:10.1371/journal.pone.0009671.g008
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of binding to the fibrinogen receptor might be of significant
biomedical interest.
Materials and Methods
Ethics statement
Blood sampling from 3 human volunteers was performed after
obtaining a written informed consent. These individuals are the
authors and co-author of this manuscript (GC, JVDA and KDR)
that have been informed on the purpose of the sample collection
that was approved by the Ethics Committee of the Institute of
Tropical Medicine (ITM), Antwerp (Belgium).
Animal ethics approval for the tsetse fly feeding on mice and
rabbits was also obtained from the Institutional Review Board of
ITM.
Chemicals
Nucleoside diphosphates and monophosphates and inhibitors
[4,49-diisothiocyanostylbene 2,29-disulfonic acid (DIDS), ouabain,
sodium orthovanadate, sodium azide, sodium fluoride, DEPC,
levamisole, P
1P
5-di(adenosine-59)pentaphosphate (AP5A), conca-
navalin A and adenosine] were purchased from Sigma. Ribonu-
cleoside and desoxyribonucleoside tri- and diphosphates were
purchased from Roche.
Tsetse flies, tissue collection and saliva harvesting
Tsetse flies (Glossina m. morsitans, ITMA colony) were available
from the insectaria at the Institute of Tropical Medicine Antwerp.
Adult male flies were starved for 72 hours prior to dissection (at
day 15 after emergence) of three different tissues: (i) the entire
midgut (posterior + anterior), (ii) the proventriculus and foregut
and (iii) the salivary glands. The tissues of 30 individuals were
pooled into microtubes containing 60 ml sterile H2O and stored at
220uC until analysis. Saliva was harvested from the salivary gland
tissue as described earlier [43], protein concentrations were
determined by the BCA kit (Pierce Biotechnology) and aliquots
stored at 220uC.
SDS-PAGE electrophoresis and protein electrotransfer
Tissue samples were thawed, homogenised with a Teflon pestle
and run under reducing and denaturing conditions on 10% SDS
PAGE. Proteins were stained with Coomassie Brilliant blue or by
silversalts, or electrotransferred to nitrocellulose (Hybond C,
Amersham) or PVDF membranes. Some protein bands were
subjected to densitometric analyses as described earlier [44].
Detection of glycosyl modifications was achieved with the Gelcode
glycoprotein staining kit (Pierce) and mobility shift assays were
performed using native and PNGase F treated saliva.
N-terminal amino acid sequencing
The N-terminal amino acid sequences of selected salivary
protein bands were determined by automated Edman degradation
in an ABI 471-B sequencer, operated as recommended by the
manufacturer.
cDNA library screening and clone isolation
A 385 base pair fragment, corresponding with the 59 part of the
59nucleotidase cDNA, was amplified using two primers that target
respectively the 59 untranslated region (sense primer: 59-
CCTAAATCCTTTCTTTAAC-39) and the region encoding the
amino-terminal part of the protein (antisense primer: 59–
CACGTGCCAGACCACCGATGC-39). To be used as a DNA
probe for screening of the lgt11 salivary gland cDNA library, the
PCR product was purified and labelled by random priming with
dUTP-digoxigenin using the DIG High Prime DNA Labeling and
Detection Starter Kit II (Roche). Approximately 20000 plaques
were lifted with Nylon membrane (Roche) and hybridized with
this specific probe. Five positive plaques were picked, confirmed by
PCR and screened an additional two rounds with the same probe.
Isolated positive plaques were amplified in the E.coli Y-1090 strain
and phage DNA was purified using the Wizard Lambda Preps
DNA Purification System (Promega).
cDNA sequence analysis and protein structure prediction
The obtained full-length cDNA was excised from the lgt11
arms with the Sfi and NotI restiction enzymes (Roche), ligated into
pGEM-13Zf(+) vector (Promega) and transformed into Top 10 E.
coli cells. Clones were sequenced using T7 and Sp6 primers as well
as custom primers constructed from the internal sequence of the
cDNA clone. Translated sequences were aligned using the
CLUSTALW program and imported into GeneDoc (www.psc.
edu/biomed/genedoc). Signal peptide prediction was based on the
SPScan program (GCG software package). Homology detection
and structure prediction was based on comparison of Hidden
Markov Models (HHpred, http://toolkit.tuebingen.mpg.de/
hhpred). Generated PDB-files were used to produce 3D-
figures using Deepview/Swiss-PdbViewer (http://www.expasy.
org/spdbv/).
59Nuc gene identification
Using G. m. morsitans salivary gland genomic DNA as a template,
a PCR was performed using a sense primer in the 59UTR (59-
CCTAAATCCTTTCTTTAAC-39) and a 39end primer (59-
ATGAATAATCGTAATGCG-39) that span the entire coding
sequence. The .4 kb amplification product was sequenced by
using an additional number of internal primers. A universal
GenomeWalker Kit (Clontech) was used to determine the 59 and
39 flanking sequences. A putative promotor sequence and the
splicing sites were identified using software analysis tools (Neural
Network Promotor prediction and Splice Site Prediction by
Neural Network) that are available at the Berkeley Drosophila
Genome project website (http://www.fruitfly.org/). The predicted
splicing sites were confirmed by comparison with the cDNA
sequence.
59Nuc cloning and recombinant expression in E. coli
The 59Nuc encoding cDNA was PCR-amplified without signal
sequence from the lgt11 Sfi-NotI fragment in pGEM13f(+) using
the GmSG4 (59-TTTTGGTCTCTAGGTGACGATTTATAT-
CCTC-39) and GmSG5 (59-TTTTGGATCCTTAATGAATA-
ATCGTAATGC–39) primers. The amplification product was
unidirectional cloned into pSUMO (LifeSensors) using BsaI and
BamHI restriction sites. The expression plasmid was transformed
in BL21(DE3) E. coli cells and expression was induced by 1 mM
isopropyl-1-thio-b-galactopyranoside (IPTG) for 3 hours at 20uC.
Next, cells were harvested, resuspended in lysis buffer [50 mM
Tris pH 8.0, 600 mM NaCl, Complete protease-inhibitor
(Roche)] and lysed by freeze-thawing and sonication. Inclusion
bodies were rinsed twice with 1% Triton-X-100 and resolubilized
in 6 M guanidinium hydrochloride in the same buffer conditions.
Recombinant 59nucleotidase purification, refolding and
antibody production
The SUMO-tagged 59Nuc was purified on Ni-NTA (Sigma),
eluted in 6 M urea with 0.5 M imidazole and refolded in pH
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5.4), MES (pH 5.6 to 6.6), HEPES (pH 6.8 to 7.8), Tris (pH 8.0 to
9.0) and piperazin (pH 9.0 to 10.0)] in the presence and absence of
additives such as 0.5 M arginine, 1 mM reduced and 0.1 mM
oxidized glutathion and 10 mM b-mercaptoethanol. Refolding
efficiency was determined by quantifying precipitation (O.D.
405 nM) and ATPase activity. For the biochemical characterisa-
tion experiments, recombinant 59Nuc was refolded in 25 mM
piperazin pH 10.0 supplemented with 250 mM NaCl, 5 mM
KCl, 2 mM CaCl2 and 2 mM MgCl2. Refolding was obtained by
a fast injection and 1/20 dilution of the 59Nuc Ni-NTA elutes (at
approximately 1 mg/ml) into the refolding buffer and incubation
for 3 to 7 days at 4uC on a rocking platform at 70 rpm. Next, the
59Nuc protein was concentrated using centrifuge concentrators
with polyethersulfone membranes and a 50 kDa molecular weight
cut-off. Concentrates were run on a Superdex 200 gelfiltration
column connected to an A ¨kta explorer (GE Healtcare), allowing
change of buffer to 1 mM piperazin pH 9.5, 100 mM NaCl and
separation of active monomeric 59Nuc from aggregates and
impurities.
59Nuc was also expressed with a T7-tag, affinity purified on a
T7-tag antibody agarose column (Novagen) and used for raising
rabbit polyclonal antiserum for Western blot analyses.
Southern, Northern and Western blot analyses and RT-
(q)PCR
AP
32 labelled probe was prepared by PCR, using primers
encompassing the entire 59nucleotidase coding sequence
(1668 bp). The same probe was used for both Southern and
Northern blot analysis. Northern blot was performed on salivary
gland RNA from adult male flies. Southern blot analysis was
performed on genomic DNA, from G. m. morsitans mixed males and
females, digested by a range of restriction enzymes (PstI, XhoI,
BamHI, BanII, SacI, EcoRI and HindIII). Western blot was used to
assess expression in different tissues using the raised rabbit anti-
59Nuc polyclonal serum (1/1000) and a peroxidase-conjugated
anti-rabbit IgG (1/1000, Sigma). Conventional and quantitative
RT-PCR analyses were performed using following primers: 59Nuc
sense (59-CGGGTAATAAAGTTCTGGTCGTA-39), 59Nuc an-
tisense (59-TTGGCAAGTCCACATTTGTTCTC-39) and prim-
ers that were used in a previous study [44]. The PCR cycles (35 for
the conventional PCR, 45 for the qPCR) consisted of 1 min.
denaturation at 94uC, 45 s. annealing at 54uC and 1 min.
extension at 72uC. Gene expression was normalized using tubulin,
actin and TAg5.
Nucleotidase activity measurements by detection of Pi
release
Zymographic detection of ATPase activity in total saliva was
performed by separating the proteins at 4uC in native conditions
on an 8% polyacrylamide gel using TAE (40 mM Tris, 5 mM
sodium acetate, 1 mM EDTA) as running buffer and applying a
voltage of 100V for 3 hours. ATPase activity was revealed by
zymography as described elsewhere [10].
Nucleotidase activities of total tsetse fly saliva and refolded
recombinant 59Nuc were measured by quantification of the Pi
release from the individual substrates (rATP, rCTP, rGTP, rUTP,
dATP, dCTP, dGTP, dTTP, rADP, rCDP, rGDP and rUDP).
Saliva (1–5 mg/ml) and recombinant 59Nuc/SUMO (2.5–5 mg/ml)
mediated activity on the substrates (20 mM) in a 200 ml reaction
volume was analysed usingthe MalachiteGreen phosphate assaykit
(Gentaur) and O.D. measurement (l=630nm) in an Ultra
microplate reader ELX808 (Bio-Tek Instruments).
For pH dependence analyses, reactions were performed in
25 mM buffers (with 100 mM NaCl) ranging from 3.0 till 12.0
with pH differences of 0.2. The used buffers were sodiumacetate
(pH 3.0 to 5.4), MES (pH 5.6 to 6.6), HEPES (pH 6.8 to 7.8), Tris
(pH 8.0 to 9.0) and piperazin (pH 9.0 to 12.0). Reactions were
performed in the presence of 1 mM of CaCl2 and MgCl2.T o
determine the cofactor preference, activity was monitored in the
presence of a range of divalent ions (Ca
2+,M g
2+,C o
2+,C d
2+,
Cu
2+,Z n
2+ and Ni
2+) at 1 mM final concentration. Temperature
optima were determined between 20u and 60uC. For kinetic
analyses, nucleotide concentrations ranged from 1000 to 0.78 mM.
Human fibrinogen receptor (GPIIb/IIIa) binding assays
Binding of 59Nuc/SUMO fusion protein to human GPIIb/IIIa
was evaluated by ELISA, largely in the same conditions as
described elsewhere [45]. Purified human fibrinogen receptor
(AssayPro), was coated at 40 nM in Nunc Maxisorb plates.
Binding of 59Nuc/SUMO (250 – 1.95 nM) onto GPIIb/IIIa was
assessed in the presence 0.1% Tween 20, either or not in
competition with varying concentrations (20 – 0.05 nM) of human
fibrinogen (Sigma), using a polyclonal anti-59Nuc IgG (1 mg/ml) or
an anti-SUMO IgG (1/2000, Lifesensors) followed by detection
with a horseradish peroxidase-conjugated anti-rabbit IgG (1/1000,
Sigma) and 3,39,5,59-tetramethylbenzidine substrate (Sigma). The
reaction was stopped by 1:3 addition of 1 M H2SO4 and optical
densities were measured at 450 nm.
Human platelet aggregation and disaggregation assays
Venous blood was obtained from healthy volunteers using
Monovette coagulation tubes (Sarstedt) resulting in an anticoag-
ulation with 10.6 mM citrate. Platelet-rich plasma (PRP) was
obtained as the upper layer after 15 min centrifugation at 1506g
at 22uC. Platelet-poor plasma (PPP), which served as the 100%
transmission baseline, was prepared by pelleting the platelets at
15006g for 15 min. Aggregation of platelets in the presence or
absence of total tsetse saliva (0.625–10 mg/ml) and the individual
59Nuc recombinant protein (10–20 mg/ml) in response to 5 and
10 mM ADP was evaluated at 37uC in a microtiter plate reader
(MultiScan Ascent, Thermo). Reduction in optical density
(increase in transmission) at 650 nm wavelength was monitored
at 15 second intervals, with 60 rpm shaking between each reading,
as a measure for platelet aggregation. For disaggregation
experiments, human platelets were maximally aggregated with a
10 mM ADP trigger, followed by the addition of saliva (1.25–
2.5 mg/ml) or recombinant 59Nuc/SUMO (10–20 mg/ml) and
O.D. measurement at 650 nm.
In vivo RNA interference (RNAi)
For the in vivo functional analysis of the 59nucleotidase, the RNA
interference (RNAi) method was applied as described previously
[44]. To generate the template for 59Nuc-specific dsRNA (length:
496 bp) production by in vitro transcription (IT), a plasmid
containing the full length 59Nuc coding sequence (pET17b:59Nuc)
was used as PCR template in combination with following primers:
59Nuc(IT) sense (59- TAATACGACTCACTATAGGGGCAGA-
CAGCTTGTACGACCA-39) and 59Nuc(IT) antisense (59-TAA-
TACGACTCACTATAGGGTCATGAATTCGATCACGGAA-
39). A control IT template was derived from pBlueScript SK(+) for
the production of a control dsRNA as described earlier[44].
Purified IT templates were transcribed using the Megascript RNAi
kit (Ambion), following the manufacturer’s instructions. DsRNA
was further purified as described previously and stored at 220uC
until fly injection.
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anaesthetised by cold shock and micro-injected intrathoracally
with a single dose of 15mg dsRNA. For the evaluation of the
transcriptional and translational silencing efficiency, 10 pairs of
glands were isolated at eight and twelve days after dsRNA
injection and saliva and RNA was purified followed by SDS-
PAGE and RT-qPCR. At day 12 after dsRNA injection, feeding
efficiencies (blood meal weights and feeding times) of individual
flies on F1 (C57Bl/66Balb/c) mice were monitored within a
maximum time of 10 minutes as described previously [43].
Supporting Information
Table S1 Similarity among selected members of the 59nucleo-
tidase family. Percentage of sequence identity and similarity (in
parenthesis) of the deduced 59nucleotidase-related protein of the
tsetse fly G. m. morsitans (AAK63848); Dros5Na and Dros5Nb,
putative 59nucleotidases of Drosophila melanogaster (Q9VZ33 and
Q9V824); chrysoptin from the deer fly Chrysops sp. (Q9U9I6);
AgApy/5N, Ag5N and AgApy, different putative apyrase/
59nucleotidase sequences of the mosquito Anopheles gambiae
(Q8MU75, Q9UB34 and Q9TW03); Ll5N, a putative 59nucleo-
tidase from the sandfly Lutzomyia longipalpis (Q9XZ43); AeApy,
Aedes aegypti mosquito apyrase (P50635); Bm5N, a 59nucleotidase
from the tick Boophilus microplus (P90696); and Hum5N, a
59nucleotidase from human Homo sapiens (P21589).
Found at: doi:10.1371/journal.pone.0009671.s001 (0.04 MB
DOC)
Table S2 59Nuc inhibitor profile. The ATP(D)ase activity of
recombinant 59Nuc was assessed in the presence of a panel of
ATPase inhibitors. Indicated are the used inhibitor concentrations
and the percentual activity with standard errors as compared to
the control setting.
Found at: doi:10.1371/journal.pone.0009671.s002 (0.03 MB
DOC)
Figure S1 59Nuc specific silencing by RNA interference.
Relative normalized 59nuc and sgp3 expression levels at days 8
and 12 in control RNAi and 59Nuc RNAi treated flies as
determined by RT-qPCR. Percentages 59Nuc silencing are
indicated above the respective bars.
Found at: doi:10.1371/journal.pone.0009671.s003 (1.25 MB TIF)
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